Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viatris Inc (NQ: VTRS )

11.78 +0.18 (+1.55%)
Official Closing Price Updated: 4:15 PM EDT, May 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,088,582
Open 11.67
Bid (Size) 11.69 (1)
Ask (Size) 11.88 (5)
Prev. Close 11.60
Today's Range 11.63 - 11.87
52wk Range 8.740 - 13.62
Shares Outstanding 1,212,301,241
Dividend Yield 4.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BTIG Research Predicts Over 118% Rally for These 3 Stocks
Wall Street stock predictions can run wild but after the tech sector's gains, these stocks could be better places for your money. 
Via InvestorPlace
Steady Returns Ahead: 3 Dividend Stocks for Stable Income in Q2
Discover three top dividend stocks for stable income in April that combine sustainable returns and long-term growth. 
Via InvestorPlace

Performance

YTD
+3.42%
+3.42%
1 Month
-2.00%
-2.00%
3 Month
-0.59%
-0.59%
6 Month
+27.08%
+27.08%
1 Year
+30.67%
+30.67%

More News

Read More
Looking Into Viatris's Recent Short Interest
Via Benzinga
Is Viatris a Great Dividend Stock or Just a Value Trap?
Via The Motley Fool
2 Dirt Cheap Dividend Stocks to Buy and Hold
Via The Motley Fool
Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris
From Scott+Scott Attorneys at Law and Hedin Hall LLP
Via Business Wire
(VTRS) - Analyzing Viatris's Short Interest
Via Benzinga
Stocks Fall Ahead Of Fed's Inflation Data, UnitedHealth Sinks, Bitcoin Tops $61,000: What's Driving Markets Wednesday?
Via Benzinga
Topics Economy
Exposures Interest Rates
Viatris And Idorsia Forge Global Partnership For Breakthrough Heart Attack Treatments
Via Benzinga
3 Overextended Stocks That Need to Slash Their Dividends ASAP
Via InvestorPlace
3 Bargain Stocks to Snatch Up Before They Bounce Back
Via InvestorPlace
Earnings Scheduled For February 28, 2024
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
The Terrible Ten
Via Talk Markets
Topics Stocks
Exposures US Equities
The Terrible Ten
Via Talk Markets
These 9 Stocks Are Running To Start 2024
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Regeneron Pharma's Pipeline Makes This Analyst Turn Bullish
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
Via Benzinga
Topics Economy
Exposures Interest Rates
Are defensive sectors ready to outshine growth in 2024?
Via MarketBeat
Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
Via Benzinga
Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth
Via Benzinga
Topics ETFs
VIATRIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Viatris Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Regeneron Celebrates Legal Win: Court Upholds Eylea Medication Patent
Via Benzinga
3 Minutes To Boost Your Earnings: 3 Stocks With Over 3% Dividend Yields In Health Care Sector From Wall Street's Most Accurate Analysts
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.